Skip to main content

Table 2 Ocular surface parameters before and after treatment(s) in the study group and in the control one

From: Outcomes of serial sessions of Activa mask combined with intense pulsed light therapy in patients with Meibomian gland dysfunction

Parameter

IPL+Activa (n=30)

IPL (control group) (n=34)

T0

T1

P

T0

T1

P

OSDI

49.8 ± 13.5

29.8 ± 10.6

< 0.001

44.8 ± 15.5

36.9 ± 11.7

< 0.001

NIBUT (s)

6.4 ± 1.7

8.6 ± 1.7

< 0.001

7.9 ± 2.9

11.4 ± 3.3

< 0.001

LLT (μm)

57.7 ± 15.5

81.3 ± 12.0

< 0.001

55.3 ± 11.2

76.2 ± 15.4

< 0.001

TMH (mm)

0.24 ± 0.06

0.024 ± 0.04

0.859

0.24 ± 0.05

0.26 ± 0.04

0.510

MGL (%)

21.1 ± 17.3

17.0 ± 14.1

0.004

28.5 ± 19.3

28.2 ± 17.3

0.637

Osmolarity (mOsm/L)

302.0 ± 8.5

295.7 ± 6.9

< 0.001

304.8 ± 11.1

302.0 ± 7.6

< 0.001

  1. OSDI ocular surface disease index, NIBUT non-invasive break-up time, LLT lipid layer thickness, TMH tear meniscus height, MGL meibomian gland loss